Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Patscheke

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Hamostaseologie|November 7, 2003
[Platelet aggregation disorders]H Patscheke
Blut|May 1, 1990
Current concepts for a drug-induced inhibition of formation and action of thromboxane A2H Patscheke
Haemostasis|January 1, 1979
Correlation of activation and aggregation of platelets. Discrimination between anti-activating and anti-aggregating agentsH Patscheke
Haemostasis|January 1, 1981
Shape and functional properties of human platelets washed with acid citrateH Patscheke
Biochemical Pharmacology|April 15, 1985
Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acidH Patscheke
Klinische Wochenschrift|May 4, 1981
[Selective anti-aggregation--a new concept for inhibitors of the platelet function (author's transl)]H Patscheke
Stroke|December 1, 1990
Thromboxane A2/prostaglandin H2 receptor antagonists. A new therapeutic principleH Patscheke
Agents and Actions. Supplements|January 1, 1992
Regulation of the concentration of free arachidonic acid in homogenates of human plateletsI Preuss, H Patscheke
Arzneimittel-Forschung|November 1, 1975
2-phenylethanol and some of its amphiphilic derivatives as inhibitors of platelet aggregation. Structure-activity relationshipR Brossmer, H Patscheke
Arzneimittel-Forschung|January 1, 1978
The effect of amphiphilic phenylalkyl derivatives on platelet energy metabolism. Stimulation of glycolysis through activation of membrane ATPaseH Patscheke, R Brossmer
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Hamostaseologie|November 7, 2003
[Platelet aggregation disorders]H Patscheke
Blut|May 1, 1990
Current concepts for a drug-induced inhibition of formation and action of thromboxane A2H Patscheke
Haemostasis|January 1, 1979
Correlation of activation and aggregation of platelets. Discrimination between anti-activating and anti-aggregating agentsH Patscheke
Haemostasis|January 1, 1981
Shape and functional properties of human platelets washed with acid citrateH Patscheke
Biochemical Pharmacology|April 15, 1985
Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acidH Patscheke
Klinische Wochenschrift|May 4, 1981
[Selective anti-aggregation--a new concept for inhibitors of the platelet function (author's transl)]H Patscheke
Stroke|December 1, 1990
Thromboxane A2/prostaglandin H2 receptor antagonists. A new therapeutic principleH Patscheke
Agents and Actions. Supplements|January 1, 1992
Regulation of the concentration of free arachidonic acid in homogenates of human plateletsI Preuss, H Patscheke
Arzneimittel-Forschung|November 1, 1975
2-phenylethanol and some of its amphiphilic derivatives as inhibitors of platelet aggregation. Structure-activity relationshipR Brossmer, H Patscheke
Arzneimittel-Forschung|January 1, 1978
The effect of amphiphilic phenylalkyl derivatives on platelet energy metabolism. Stimulation of glycolysis through activation of membrane ATPaseH Patscheke, R Brossmer
Pageof 5